Aller au contenu
Aperlena
Langue:

Ireland - Laboratory reagents - Provision of Flow Cytometry Reagents, Antibodies, Platform-Specific Consumables and Single-Cell Genomics Reagents for Ongoing Research Activities

Attribué Avis d'attribution Aucune date limite publiée
Suivre ce marché

Les offres sont closes. Une attribution ou un rectificatif sur cet avis : un e-mail quand le registre le voit. Se connecter

  1. Attribué
  2. Publié

Description

This voluntary ex-ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to put in place a contract with Becton Dickinson UK Ltd, 1030 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TS for the provision of flow cytometry reagents, antibodies, platform-specific consumables and single-cell genomics reagents required to support ongoing research activities across the University. The requirement encompasses specialised laboratory reagents, including fluorochrome-conjugated monoclonal antibodies, staining buffers, assay kits, instrument calibration materials, and proprietary consumables associated with BD flow cytometry and BD Rhapsody single-cell genomics platforms. These products are integral to established experimental workflows across multiple research groups, including immunophenotyping, cell signalling analysis and single-cell gene expression studies. Trinity College Dublin intends to award this contract in accordance with Article 32(2)(b)(ii) of Directive 2014/24/EU, on the basis that competition is absent for technical reasons. The required reagents are defined by specific antibody clones and fluorochrome conjugations, many of which are proprietary and are embedded within validated experimental protocols. Substitution would necessitate extensive re-validation, introduce scientific risk and delay research outputs. In addition, platform-specific consumables, including BD Rhapsody cartridge and cDNA kits are required for the operation of existing instrumentation and cannot be replaced with alternative products. While certain items may be available via resellers, this does not represent a viable alternative, as it introduces additional cost without addressing technical compatibility or continuity requirements. Accordingly, the proposed approach is necessary to ensure continuity of research and represents a proportionate and compliant procurement solution. This voluntary ex-ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to put in place a contract with Becton Dickinson UK Ltd, 1030 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TS for the provision of flow cytometry reagents, antibodies, platform-specific consumables and single-cell genomics reagents required to support ongoing research activities across the University. The requirement encompasses specialised laboratory reagents, including fluorochrome-conjugated monoclonal antibodies, staining buffers, assay kits, instrument calibration materials, and proprietary consumables associated with BD flow cytometry and BD Rhapsody single-cell genomics platforms. These products are integral to established experimental workflows across multiple research groups, including immunophenotyping, cell signalling analysis, and single-cell gene expression studies. Trinity College Dublin intends to award this contract in accordance with Article 32(2)(b)(ii) of Directive 2014/24/EU, on the basis that competition is absent for technical reasons. The required reagents are defined by specific antibody clones and fluorochrome conjugations, many of which are proprietary, and are embedded within validated experimental protocols. Substitution would necessitate extensive re-validation, introduce scientific risk, and delay research outputs. In addition, platform-specific consumables, including BD Rhapsody cartridge and cDNA kits, are required for the operation of existing instrumentation and cannot be replaced with alternative products. While certain items may be available via resellers, this does not represent a viable alternative, as it introduces additional cost without addressing technical compatibility or continuity requirements. Accordingly, the proposed approach is necessary to ensure continuity of research and represents a proportionate and compliant procurement solution.

Source officielle

Source : TED - Tenders Electronic Daily (Publications Office of the EU)

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de TED - Tenders Electronic Daily (Publications Office of the EU) il y a 1 mois

Consulter l'avis officiel

Plus de cet acheteur

Profil complet de l'acheteur

7 marchés ouverts actuellement

Attributions récentes

Historique des modifications

Chaque republication de cet avis par une source officielle avec un contenu différent. Nous surveillons toutes les sources que nous indexons, y compris les copies régionales du même avis.

  1. A lire avant de repondre
    • Date d'attribution: Attribué le 20 avril 2026
    • Objet et critères: La description a été étoffée. À relire avant de repondre.

Suivez ce marche et nous vous ecrivons dès qu'il change. Créer un compte

Marchés similaires

Contexte de marché

Appel ouvert moyen · Équipements médicaux & produits pharmaceutiques
10 142 739 €
9 882 ouverts en Europe actuellement
Historique de l'acheteur sur Aperlena
119 avis suivis · 84 attribués
210 780 816 € de contrats attribués

Ne manquez plus aucun marché comme celui-ci

2 nouveaux avis pour Équipements médicaux & produits pharmaceutiques en Irlande au cours des 7 derniers jours. Recevez un e-mail quand de nouveaux avis paraissent. Gratuit.

Créer mon alerte
Source

Raccourcis clavier

Parcourir une liste sans toucher la souris. Les raccourcis restent inactifs pendant la saisie dans un champ.

j
Résultat suivant
k
Résultat précédent
Entrée
Ouvrir le résultat
n
Page suivante
p
Page précédente
c
Comparer ce résultat
s
Ajouter ce résultat à la présélection
/
Aller au champ de recherche
?
Afficher ces raccourcis
Échap
Fermer